CHICAGO — ALK-001, a vitamin A replacement, helped slow the growth rate of atrophic lesions in patients with Stargardt disease, according to a study presented at the American Academy of Ophthalmology meeting.
Christine Kay, MD, said supply of vitamin A is critical for vision, but it can form toxic by-products as a result of the visual cycle in patients with Stargardt disease.
“Eliminating or slowing vitamin A is not a good option as it leads to night blindness, delayed dark adaptation and possibly long-term retinal degeneration or other ocular and systemic side effects,” Kay